Evidence map›Paper›PMID 31178964›Full record

ArticleOxidative medicine and cellular longevity2019

The Protective Roles of Estrogen Receptor

Wei Zhu, Zhijian Zhao, Fu-Ju Chou, Li Zuo, Tongzu Liu, David Bushinsky, Chawnshang Chang, Guohua Zeng, Shuyuan Yeh

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Metabolic changes in kidney stone disease.Frontiers in immunology · 2023
    Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Carboxymethylation ofOxidative medicine and cellular longevity · 2022
    Article
  14. Article
  15. Urinary Microbial and Metabolomic Profiles in Kidney Stone Disease.Frontiers in cellular and infection microbiology · 2022
    Article
  16. Article
  17. Recent advances on the mechanisms of kidney stone formation (Review).International journal of molecular medicine · 2021
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Wei ZhuDepartment of Urology and Guangdong Key Lab of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.
Zhijian ZhaoDepartment of Urology and Guangdong Key Lab of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.
Fu-Ju ChouDepartments of Urology and Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Li ZuoDepartments of Urology and Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Tongzu LiuDepartments of Urology and Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
David BushinskyDepartment of Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Chawnshang ChangDepartments of Urology and Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Guohua ZengDepartment of Urology and Guangdong Key Lab of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China.ORCID 0000-0002-3110-8933
Shuyuan YehDepartments of Urology and Pathology, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-5329-2321
University of Rochester Medical Center · USFirst Affiliated Hospital of Guangzhou Medical University · CN

Funding

Non-AR mediated DHT-promoted Bladder Cancer initiation and progressionR01CA155477 · NCI · UNIVERSITY OF ROCHESTER · PI CHANG, CHAWNSHANG · 2011 to 2015
$1.6M
Stromal AR Roles in Prostate Hyperplasia and CancerR01CA156700 · NCI · UNIVERSITY OF ROCHESTER · PI CHANG, CHAWNSHANG, YEH, SHUYUAN · 2011 to 2015
$1.6M
NCI NIH HHS R01 CA155477NCI NIH HHS R01 CA156700
6 · The paper itself

Abstract

Females develop kidney stones less frequently than males do. However, it is unclear if this gender difference is related to altered estrogen/estrogen receptor (ER) signaling. Here, we found that ER beta (ER

Indexed as

AnimalsCalcium OxalateEstrogen Receptor betaFemaleHEK293 CellsHep G2 CellsHumansKidneyKidney CalculiLiverMaleMiceMice, KnockoutOxidative StressCalcium OxalateESR2 protein, humanEstrogen Receptor beta

Identifiers

PMID31178964
PMCPMC6501165
OpenAlexW2938369986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.